Pharmacogenetics and Ethnoracial Differences in Smoking
- 8 July 1998
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 280 (2) , 179-180
- https://doi.org/10.1001/jama.280.2.179
Abstract
More than 1.1 billion people smoke tobacco worldwide, but they do so in different patterns and with strikingly different consequences. For example, more than 5Keywords
This publication has 9 references indexed in Scilit:
- Nicotine Metabolism and Intake in Black and White SmokersJAMA, 1998
- The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergencePharmacogenetics, 1997
- CYP2A6 gene polymorphism and risk of liver cancer and cirrhosisPharmacogenetics, 1997
- Genetic polymorphism of CYP2D6 and lung cancer risk in African- Americans and Caucasians in Los Angeles CountyCarcinogenesis: Integrative Cancer Research, 1997
- Effect of Menthol Cigarettes on Biochemical Markers of Smoke Exposure Among Black and White SmokersChest, 1996
- Cotinine as a Biomarker of Environmental Tobacco Smoke ExposureEpidemiologic Reviews, 1996
- Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepamPharmacogenetics, 1995
- Race and Sex Differences in Lung Cancer Risk Associated with Cigarette SmokingInternational Journal of Epidemiology, 1993
- Pharmacologic Aspects of Cigarette Smoking and Nicotine AddictionNew England Journal of Medicine, 1988